Schizophrenia - Market Insights, Epidemiology and Market Forecast - 2030 ... compared to other therapies. SEP-363856: Sunovion/PsychoGenics SEP-363856 is an orally active, ... and other psychiatric conditions. SEP-363856 was discovered utilizing a ... Cellular Therapies), Latuda (lurasidone hydrochloride, Sunovion Pharmaceuticals/Sumitomo ...